廣發證券(000776.SZ)受讓廣發基金9.458%股權已完成工商變更登記
格隆匯11月14日丨廣發證券(000776.SZ)公佈,2019年1月28日,公司召開第九屆董事會第十七次會議,審議同意公司受讓康美藥業持有的廣發基金管理有限公司(“廣發基金”)9.458%股權。此後,中國證券監督管理委員會出具《關於核准廣發基金管理有限公司變更股權的批覆》(證監許可[2019]1948號),核准康美藥業將持有的廣發基金9.458%股權轉讓給公司。
近日,廣發基金已根據上述批覆,完成了工商變更登記,並獲得了廣東省市場監督管理局換髮的新營業執照。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.